Respiratory drugs specialist Vectura Group Plc (VEC.L) appointed AstraZeneca (AZN.L) executive James Ward-Lilley as chief executive officer effective Oct. 1.
Ward-Lilley replaces Chris Blackwell, who will leave the company at the end of this month.
14:53 Netflix fueled by original programming, even as its costs hold earnings back, analysts say14
16:16 Luxottica, Essilor $24 billion merger creates eyewear giant18
07:24 Burberry's CEO designate to join firm this month22
05:02 Ringling Bros. and Barnum & Bailey Circus to close after 146 years14